Advertisement
Screener

Miromatrix Medical Inc. Selling, General and Administrative Expense

Miromatrix Medical Inc. Selling, General and Administrative Expense

Miromatrix Medical Inc. reported Selling, General and Administrative Expense of $2.14 million for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-14.

Discontinued › Expense Statement › Operating Expenses

us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2023-11-14

  • Miromatrix Medical Inc. selling, general and administrative expense for the quarter ending 2023-09-30 was $2.14M, a 4.42% increase year-over-year.
  • Miromatrix Medical Inc. selling, general and administrative expense for the quarter ending 2023-06-30 was $2.04M, a 6.89% decline year-over-year.
  • Miromatrix Medical Inc. selling, general and administrative expense for the quarter ending 2023-03-31 was $2.60M, a 14.42% increase year-over-year.
  • Miromatrix Medical Inc. selling, general and administrative expense for the quarter ending 2022-12-31 was $2.21M, a 22.11% increase year-over-year.
  • Miromatrix Medical Inc. selling, general and administrative expense for fiscal 2022 was $8.72M, a 87.79% increase from fiscal 2021.
  • Miromatrix Medical Inc. selling, general and administrative expense for fiscal 2021 was $4.64M, a 120.15% increase from fiscal 2020.
  • Miromatrix Medical Inc. selling, general and administrative expense for fiscal 2020 was $2.11M.
Period endSelling, General and Administrative Expense 3 monthSelling, General and Administrative Expense 6 monthSelling, General and Administrative Expense 6 month as first filedSelling, General and Administrative Expense 9 monthSelling, General and Administrative Expense 12 month
2023-09-30$2.14M
10-Q · filed 2023-11-14
$4.18M
derived: sum of 2 quarters · filed 2023-11-14
$6.78M
10-Q · filed 2023-11-14
$8.99M
derived: sum of 4 quarters · filed 2023-11-14
2023-06-30$2.04M
10-Q · filed 2023-08-14
$4.64M
10-Q · filed 2023-08-14
$6.84M
derived: sum of 3 quarters · filed 2023-08-14
$8.90M
derived: sum of 4 quarters · filed 2023-11-14
2023-03-31$2.60M
10-Q · filed 2023-05-11
$4.81M
derived: sum of 2 quarters · filed 2023-05-11
$6.86M
derived: sum of 3 quarters · filed 2023-11-14
$9.05M
derived: sum of 4 quarters · filed 2023-11-14
2022-12-31$2.21M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31
$4.26M
derived: sum of 2 quarters · filed 2023-11-14
$6.45M
derived: sum of 3 quarters · filed 2023-11-14
$8.72M
10-K · filed 2023-03-31
2022-09-30$2.05M
10-Q · filed 2023-11-14
$4.24M
derived: sum of 2 quarters · filed 2023-11-14
$6.51M
10-Q · filed 2023-11-14
$8.32M
derived: sum of 4 quarters · filed 2023-11-14
2022-06-30$2.19M
10-Q · filed 2023-08-14
$4.46M
10-Q · filed 2023-08-14
$4.46M
10-Q · filed 2022-08-15
$6.27M
derived: sum of 3 quarters · filed 2023-08-14
$7.76M
derived: sum of 4 quarters · filed 2023-08-14
2022-03-31$2.27M
10-Q · filed 2023-05-11
$4.08M
derived: sum of 2 quarters · filed 2023-05-11
$5.57M
derived: sum of 3 quarters · filed 2023-05-11
$6.35M
derived: sum of 4 quarters · filed 2023-05-11
2021-12-31$1.81M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31
$3.29M
derived: sum of 2 quarters · filed 2023-03-31
$4.08M
derived: sum of 3 quarters · filed 2023-03-31
$4.64M
10-K · filed 2023-03-31
2021-09-30$1.49M
10-Q · filed 2022-11-14
$2.27M
derived: sum of 2 quarters · filed 2022-11-14
$2.84M
10-Q · filed 2022-11-14
$3.42M
derived: sum of 4 quarters · filed 2022-11-14
2021-06-30$786.32K
10-Q · filed 2022-08-15
$1.35M
10-Q · filed 2022-08-15
$1.93M
derived: sum of 3 quarters · filed 2022-08-15
$2.39M
derived: sum of 4 quarters · filed 2022-08-15
2021-03-31$562.87K
10-Q · filed 2022-05-16
$1.14M
derived: sum of 2 quarters · filed 2022-05-16
$1.60M
derived: sum of 3 quarters · filed 2022-05-16
$2.21M
derived: sum of 4 quarters · filed 2022-05-16
2020-12-31$578.28K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30
$1.04M
derived: sum of 2 quarters · filed 2022-03-30
$1.64M
derived: sum of 3 quarters · filed 2022-03-30
$2.11M
10-K · filed 2022-03-30
2020-09-30$460.11K
10-Q · filed 2021-11-15
$1.07M
derived: sum of 2 quarters · filed 2021-11-15
$1.53M
10-Q · filed 2021-11-15
2020-06-30$605.15K
10-Q · filed 2021-08-12
$1.07M
10-Q · filed 2021-08-12